The National Cardiovascular Health Program (CDC RFA DP 23 0004)

The National Cardiovascular Health Program (CDC RFA DP 23 0004) is sponsored by Centers for Disease Control and Prevention (CDC). This cooperative agreement aims to help jurisdictions implement and evaluate evidence-based strategies for preventing and managing cardiovascular disease, with a focus on high-risk populations and reducing disparities.

A **. gov** website belongs to an official government organization in the United States.

* How to Apply for Grants * **Applicant Resources** * Adobe Software Compatibility * Submitting UTF-8 Special Characters * Encountering Error Messages * Grantor Standard Language * Submitting UTF-8 Special Characters * **Applicant System-To-System** * Reference Implementation * **Grantor System-To-System** * Reference Implementation * SF-424 Individual Family * SF-424 Mandatory Family * SF-424 Short Organization Family * Post-Award Reporting Forms * Country and State Lists Updates * **Manage Subscriptions** * Program Management Office * Grants.

gov Maintenance Calendar The National Cardiovascular Health Program Department of Health and Human Services Centers for Disease Control - NCCDPHP Document Type:Grants Notice Funding Opportunity Number:CDC-RFA-DP-23-0004 Funding Opportunity Title:The National Cardiovascular Health Program Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Cooperative Agreement Category of Funding Activity:Health Expected Number of Awards:51 Assistance Listings:93.

426 -- Improving the Health of Americans through Prevention and Management of Diabetes and Heart Disease and Stroke Cost Sharing or Matching Requirement:No Last Updated Date:Feb 24, 2023 Original Closing Date for Applications:Apr 25, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.

Current Closing Date for Applications:Apr 25, 2023 Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.

Archive Date:May 25, 2023 Estimated Total Program Funding:$ 275,000,000 Eligible Applicants:Others (see text field entitled "Additional Information on Eligibility" for clarification) Additional Information on Eligibility:Per the program’s authorizing statute or regulation: Sec 317(a) of the Public Health Service Act [42 USC 247b] only State governments, including the District of Columbia, or their bona fide agents are eligible to apply.

Local health departments are eligible to compete under a separate NOFO (The Innovative Cardiovascular Health Program), and Tribes and Tribal-serving organizations are and will continue to be funded under separate NOFOs (https://www. cdc. gov/healthytribes/index.

htm). FY22 House Report language asserts the significant increases to DHDSP’s budget allocations should be directed to “support, strengthen, and expand current evidence-based initiatives at the State, local, tribal, and territorial level.

” Committee language further supports a continuation of DHDSP’s current efforts and “recognizes the vital importance of addressing cardiovascular disease among women and underserved communities, communities of color, those communities with limited access to information about cardiovascular health disease, and communities at risk for delaying regular monitoring of cardiovascular health as a result of the COVID–19 pandemic.

The Committee supports CDC’s efforts to improve our understanding of the outcomes and health effects of COVID–19 infection, including cardiovascular disease. ” [House Committee Report 117-96, p. 89.

Available at: CRPT-117hrpt96. pdf (congress. gov)]More recently, FY23 House Report language directs efforts to “support, strengthen, and expand evidence-based initiatives at the State, local, tribal, and territorial level.

The Committee recognizes the vital importance of addressing cardiovascular disease among women, particularly women of color, and further recognizes that the resulting costs to the health care system of unrecognized cardiovascular disease in women can be substantially reduced with appropriate public awareness and prevention”. [FY23 House Report 117-403, p. 80.

Available at:CRPT-117hrpt403. pdf (congress. gov)]FY23 Explanatory Statement asserts the agreement includes an increase to strengthen and expand evidence-based heart disease and stroke prevention activities focused on high risk populations.

Applicants should refer to the funding table for specific funding amounts for each state. ## Additional Information Agency Name:Centers for Disease Control - NCCDPHP Description:This NOFO aims to implement and evaluate evidence-based strategies contributing to the prevention and management of CVD in populations at the highest risk.

However, given the importance of health equity, this new NOFO also addresses social and economic factors to help health systems respond to social determinants present in their communities to offer those at risk of, or burdened with CVD, the best health outcomes possible. Link to Additional Information:[](https://grants.

gov/search-results-detail/342935) Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: #### Health & Human Services * Frequently Asked Questions ## Your session will expire in 3 minutes. To continue working, click on the "OK" button below. This is being done to protect your privacy.

Unsaved changes will be lost.